PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Naproxen - Pain & inflammation - musculoskeletal
PAD Profile : Naproxen - Pain & inflammation - musculoskeletal
Keywords :
PNMP, NSAID, osteoarthritis, rheumatic disease, musculoskeletal pain
Brand Names Include :
Naprosyn
Traffic Light Status
Status 1 of 3.
Status :
Green
Preferred
Formulations :
- Tablets
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Comments :
No comments returned.
Documents :
Status 2 of 3.
Status :
Green (see narrative)
Important
Formulations :
- Effervescent tablets
- Oral suspension
Important Information :
Effervescent tablets and oral suspension are much more expensive and should be reserved for patients in whom ibuprofen suspension is not suitable. Reserve oral suspension for patients with sodium restriction or for children.
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Comments :
No comments returned.
Documents :
Status 3 of 3.
Guidelines
No guidelines returned.
Other Drugs
- Celecoxib
- Diclofenac sodium
- Diclofenac sodium
- Naproxen
- Etoricoxib
- Ibuprofen
- Meloxicam
- Aceclofenac
- Diclofenac potassium
- Indometacin
- Nabumetone
- Etodolac
- Ketoprofen
- Mefenamic acid
Other Indications
Additional Documents
No additional documents returned.
Committee Recommendations
Date
Committee Name
Narrative
07 August 2019
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
A stepped approach to pain management is recommended. Paracetamol is considered a 1st line option for the treatment of pain. Consider initiation of an oral NSAID as an adjunct to paracetamol if required. See the guidelines attached for further information.
PLEASE NOTE: Naproxen effervescent tablets or naproxen oral suspension, should only be used where a patient with swallowing difficulties caanot tolerate ibuprofen suspension or ibuprofen suspension is ineffective.
Associated BNF Codes
10. Musculoskeletal and Joint Diseases
10.01.01. Non-steroidal anti-inflammatory drugs